Indivior PLC (INDV)
USD 9.44
(3.62%)
USD 9.44
(3.62%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.95 Billion USD | 12.97% |
| 2022 | 1.72 Billion USD | 6.24% |
| 2021 | 1.62 Billion USD | 12.2% |
| 2020 | 1.44 Billion USD | 0.42% |
| 2019 | 1.44 Billion USD | -2.57% |
| 2018 | 1.48 Billion USD | -10.08% |
| 2017 | 1.64 Billion USD | 9.51% |
| 2016 | 1.5 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.63 Billion USD | -1.53% |
| 2024 Q2 | 1.65 Billion USD | 14.87% |
| 2024 Q1 | 1.44 Billion USD | -26.1% |
| 2023 FY | 1.95 Billion USD | 12.97% |
| 2023 Q4 | 1.95 Billion USD | 4.08% |
| 2023 Q3 | 1.87 Billion USD | 16.34% |
| 2023 Q2 | 1.61 Billion USD | -4.01% |
| 2023 Q1 | 1.67 Billion USD | -2.81% |
| 2022 Q1 | 1.48 Billion USD | -8.46% |
| 2022 Q2 | 1.49 Billion USD | 0.34% |
| 2022 Q3 | 1.44 Billion USD | -3.32% |
| 2022 Q4 | 1.72 Billion USD | 19.65% |
| 2021 Q4 | 1.62 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 947.87 Million USD | -105.854% |
| Embecta Corp. | 2.03 Billion USD | 4.168% |
| ANI Pharmaceuticals, Inc. | 471.67 Million USD | -313.685% |
| Dynavax Technologies Corporation | 375.02 Million USD | -420.298% |
| Esperion Therapeutics, Inc. | 660.79 Million USD | -195.289% |
| Pacira BioSciences, Inc. | 704.25 Million USD | -177.064% |
| PainReform Ltd. | 2.69 Million USD | -72409.884% |
| Aquestive Therapeutics, Inc. | 163.9 Million USD | -1090.471% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -31681.239% |
| SCYNEXIS, Inc. | 55.45 Million USD | -3418.92% |
| China SXT Pharmaceuticals, Inc. | 9.19 Million USD | -21116.957% |
| Cosmos Health Inc. | 30.25 Million USD | -6349.845% |
| Journey Medical Corporation | 56.49 Million USD | -3353.585% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -31681.239% |
| Safety Shot Inc | 3.89 Million USD | -50034.093% |
| Alpha Teknova, Inc. | 38.55 Million USD | -4961.454% |
| Intra-Cellular Therapies, Inc. | 136.87 Million USD | -1325.606% |
| Bright Green Corporation | 6.43 Million USD | -30207.705% |
| Procaps Group, S.A. | 462.06 Million USD | -322.287% |
| Theratechnologies Inc. | 98.63 Million USD | -1878.164% |
| Harrow Health, Inc. | 241.75 Million USD | -707.122% |
| Sonoma Pharmaceuticals, Inc. | 8.75 Million USD | -22184.616% |
| Biofrontera Inc. | 23.13 Million USD | -8332.694% |
| DURECT Corporation | 30.4 Million USD | -6317.289% |
| Supernus Pharmaceuticals, Inc. | 487.46 Million USD | -300.287% |
| Cronos Group Inc. | 43.73 Million USD | -4361.399% |
| OptiNose, Inc. | 194.33 Million USD | -904.061% |
| Ironwood Pharmaceuticals, Inc. | 817.36 Million USD | -138.722% |
| Kala Pharmaceuticals, Inc. | 48.44 Million USD | -3927.745% |
| RedHill Biopharma Ltd. | 20.97 Million USD | -9201.313% |
| Organogenesis Holdings Inc. | 181.36 Million USD | -975.882% |
| Guardion Health Sciences, Inc. | 3.77 Million USD | -51627.775% |
| Cumberland Pharmaceuticals Inc. | 52.51 Million USD | -3615.503% |
| Radius Health, Inc. | 804.29 Million USD | -142.604% |
| Universe Pharmaceuticals INC | 13.75 Million USD | -14086.375% |
| ProPhase Labs, Inc. | 42.54 Million USD | -4486.407% |
| Phibro Animal Health Corporation | 725.54 Million USD | -168.935% |
| Procaps Group S.A. | 462.06 Million USD | -322.287% |
| Alvotech | 1.88 Billion USD | -3.647% |
| TherapeuticsMD, Inc. | 14.02 Million USD | -13815.568% |
| Viatris Inc. | 27.21 Billion USD | 92.831% |
| Rockwell Medical, Inc. | 30.88 Million USD | -6218.376% |
| Aytu BioPharma, Inc. | 90.37 Million USD | -2058.954% |
| SIGA Technologies, Inc. | 57.97 Million USD | -3265.527% |
| Tilray Brands, Inc. | 892.11 Million USD | -118.72% |
| Lifecore Biomedical, Inc. | 219.8 Million USD | -787.735% |
| Shineco, Inc. | 47.6 Million USD | -3999.101% |
| PetIQ, Inc. | 645.22 Million USD | -202.411% |
| Regencell Bioscience Holdings Limited | 219.51 Thousand USD | -888799.458% |
| Incannex Healthcare Limited | 5.83 Million USD | -33368.97% |
| Neurocrine Biosciences, Inc. | 1.01 Billion USD | -91.411% |
| Alimera Sciences, Inc. | 107.35 Million USD | -1717.576% |
| Silver Spike Investment Corp. | 3 Million USD | -64728.922% |
| Assertio Holdings, Inc. | 148.41 Million USD | -1214.711% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.89 Million USD | -102815.454% |
| Petros Pharmaceuticals, Inc. | 21.31 Million USD | -9053.978% |
| Clever Leaves Holdings Inc. | 7.02 Million USD | -27671.719% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -22881.377% |
| Avadel Pharmaceuticals plc | 173.38 Million USD | -1025.368% |
| Hempacco Co., Inc. | 18.82 Million USD | -10266.587% |
| Talphera, Inc. | 6.29 Million USD | -30921.319% |
| Alvotech | 1.88 Billion USD | -3.647% |
| Eagle Pharmaceuticals, Inc. | 172.6 Million USD | -1030.499% |
| Lantheus Holdings, Inc. | 835.25 Million USD | -133.61% |
| Currenc Group, Inc. | 177.67 Million USD | -998.203% |
| Kamada Ltd. | 109.96 Million USD | -1674.367% |
| Evoke Pharma, Inc. | 9.64 Million USD | -20124.131% |
| Flora Growth Corp. | 17.22 Million USD | -11229.933% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -22881.377% |
| Evolus, Inc. | 209.68 Million USD | -830.549% |
| HUTCHMED (China) Limited | 536.38 Million USD | -263.776% |
| Amphastar Pharmaceuticals, Inc. | 873.49 Million USD | -123.384% |
| Akanda Corp. | 12.66 Million USD | -15301.837% |